Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation.

MLA

Bell S., et al. Prognostic Role of Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Treated with Repeat Transarterial Chemoembolisation. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305131348&authtype=sso&custid=ns315887.

APA

Bell S., Nicoll A., Roberts S.K., Kemp W., Majeed A., Mishra G., Dev A., Paul E., Cheung W., Koukounaras J., Jhamb A., Marginson B., Lim B.G., Simkin P., Borsaru A., Burnes J., Goodwin M., Ramachandra V., Spanger M., … Ryan M. (2020). Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation.

Chicago

Bell S., Nicoll A., Roberts S.K., Kemp W., Majeed A., Mishra G., Dev A., et al. 2020. “Prognostic Role of Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Treated with Repeat Transarterial Chemoembolisation.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305131348&authtype=sso&custid=ns315887.